Pim-1 protein expression is regulated by its 5'-untranslated region and translation initiation factor elF-4E

Cell Growth and Differentiation

Volumn 8, Issue 12, 1997, Pages 1371-1380

  Hoover, D S ^a   Wingett, D G ^a,b   Zhang, J ^a   Reeves, R ^a   Magnuson, N S ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b Boise VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; INITIATION FACTOR; IONOMYCIN; MESSENGER RNA; NUCLEOTIDE; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECONDARY STRUCTURE; RNA TRANSLATION; TRANSLATION INITIATION;

3T3 CELLS; ANIMALS; BASE SEQUENCE; BETA-GALACTOSIDASE; CELL LINE; EUKARYOTIC INITIATION FACTOR-4E; HUMANS; METHIONINE; MICE; MOLECULAR SEQUENCE DATA; NIGERICIN; NUCLEIC ACID CONFORMATION; PEPTIDE INITIATION FACTORS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-PIM-1; RETICULOCYTES; RNA, MESSENGER; SEQUENCE ANALYSIS, RNA; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION, GENETIC; TRANSFECTION;

ANIMALIA; EUKARYOTA;

EID: 0031442452     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Saris, C. J., Domen, J., and Berns, A. The pim-1 oncogene encodes two related protein-serine/threonine kinases by alternative initiation at AUG and CUG. EMBO J., 10: 655-664, 1991.
2. Padma, R., and Nagarajan, L. The human PIM-1 gene product is a protein serine kinase. Cancer Res., 51: 2486-2489, 1991.
3. Hoover, D., Friedmann, M., Reeves, R., and Magnuson, N. S. Recombinant human pim-1 protein exhibits serine/threonine kinase activity. J. Biol. Chem., 266: 14018-14023, 1991.
4. Berns, A., Cuypers, H. T., Selten, G., and Domen, J. In: N. O. Kjeldaard and J. Forchhammer (eds.), Viral Carcinogenesis, pp. 211-230. Copenhagen: Raven Press, 1987.
5. Amson, R., Sigaux, F., Przedborski, S., Flandrin, G., Givol, D., and Telerman, A. The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias. Proc. Natl. Acad. Sci. USA, 86: 8857-8861, 1989.
6. Sorrentino, V., McKinney, M. D., Giorgi, M., Geremia, R., and Fleissner, E. Expression of cellular protooncogenes in the mouse male germ line: a distinctive 2.4-kilobase pim-1 transcript is expressed in haploid postmeiotic cells. Proc. Natl. Acad. Sci. USA, 85: 2191-2195, 1988.
7. van Lohuizen, M., Verbeek, S., Krimpenfort, P., Domen, J., Saris, C., Radaszkiewicz, T., and Berns, A. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell, 56: 673-682, 1989.
8. Breuer, M., Wientjens, E., Verbeek, S., Slebos, R., and Berns, A. Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras. Cancer Res., 51: 958-963, 1991.
9. Acton, D., Domen, J., Jacobs, H., Vlaar, M., Korsmeyer, S., and Berns, A. Collaboration of pim-1 and bcl-2 in lymphomagenesis. Curr. Top. Microbiol. Immunol., 182: 293-298, 1992.
10. Dautry, F., Weil, D., Yu, J., and Dautry Varsat, A. Regulation of pim and myb mRNA accumulation by interleukin 2 and interleukin 3 in murine hematopoietic cell lines. J. Biol. Chem., 263: 17615-17620, 1988.
11. Lilly, M., Le, T., Holland, P., and Hendrickson, S. L. Sustained expression of the pim-1 kinase is specifically induced in myeloid cells by cytokines whose receptors are structurally related. Oncogene, 7: 727-732, 1992.
12. Sato, N., Sakamaki, K., Terada, N., Arai, K., and Miyajima, A. Signal transduction by the high-affinity GM-CSF receptor: two distinct cytoplasmic regions of the common β subunit responsible for different signaling. EMBO J., 12: 4181-4189, 1993.
13. Domen, J., van der Lugt, N. M., Laird, P. W., Saris, C. J., Clarke, A. R., Hooper, M. L., and Berns, A. Impaired interleukin-3 response in Pim-1-deficient bone marrow-derived mast cells. Blood, 82: 1445-1452, 1993.
14. Quelle, F. W., Sato, N., Witthuhn, B. A., Inhorn, R. C., Eder, M., Miyajima, A., Griffin, J. D., and Ihle, J. N. JAK2 associates with the β c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol. Cell. Biol., 14: 4335-4341, 1994.
15. Miura, O., Miura, Y., Nakamura, N., Quelle, F. W., Witthuhn, B. A., Ihle, J. N., and Aoki, N. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor. Blood, 84: 4135-4141, 1994.
16. Yip Schneider, M. T., Horie, M., and Broxmeyer, H. E. Transcriptional induction of pim-1 protein kinase gene expression by interferon γ and posttranscriptional effects on costimulation with steel factor. Blood, 85: 3494-3502, 1995.
17. Buckley, A. R., Buckley, D. J., Leff, M. A., Hoover, D. S., and Magnuson, N. S. Rapid induction of pim-1 expression by prolactin and interleukin-2 in rat Nb2 lymphoma cells. Endocrinology, 136: 5252-5259, 1995.
18. Moray, T., Grzeschiczek, A., Petzold, S., and Hartmann, K. U. Expression of a Pim-1 transgene accelerates lymphoproliferation and inhibits apoptosis in lpr/lpr mice. Proc. Natl. Acad. Sci. USA, 90: 10734-10738, 1993.
19. Takahashi, C., Harada, Y., Ariga, H., and Iguchi Ariga, S. M. Involvement of PIM-1 in DNA fragmentation in mouse NS-1-derived cells. Biochem. Biophys. Res. Commun., 215: 538-546, 1995.
20. Meeker, T. C., Loeb, J., Ayres, M., and Sellers, W. The human Pim-1 gene is selectively transcribed in different hemato-lymphoid cell lines in spite of a G+C-rich housekeeping promoter. Mol. Cell. Biol., 10: 1680-1688, 1990.
21. Wingett, D., Reeves, R., and Magnuson, N. S. Stability changes in pim-1 proto-oncogene mRNA after mitogen stimulation of normal lymphocytes. J. Immunol., 147: 3653-3659, 1991.
22. Liang, H., Hittelman, W., and Nagarajan, L. Ubiquitous expression and cell cycle regulation of the protein kinase PIM-1. Arch. Biochem. Biophys., 330: 259-265, 1996.
23. Wingett, D., Long, A., Kelleher, D., and Magnuson, N. S. pim-1 protooncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1. J. Immunol., 156: 549-557, 1996.
24. Rohwer, F., Todd, S., and McGuire, K. L. The effect of IL-2 treatment on transcriptional attenuation in protooncogenes pim-1 and c-myb in human thymic blast cells. J. Immunol., 157: 643-649, 1996.
25. Kozak, M. An analysis of vertebrate mRNA sequences: intimations of translational control. J. Cell. Biol., 115: 887-903, 1991.
26. Kozak, M. Structural features in eukaryotic mRNAs that modulate the initiation of translation. J. Biol. Chem., 266: 19867-19870, 1991.
27. Geballe, A. P., and Morris, D. R. Initiation codons within 5′-leaders of mRNAs as regulators of translation. Trends Biochem. Sci., 19: 159-164, 1994.
28. Avni, D., Shama, S., Loreni, F., and Meyuhas, O. Vertebrate mRNAs with a 5′-terminal pyrimidine tract are candidates for translational repression in quiescent cells: characterization of the translational cis-regulatory element. Mol. Cell. Biol., 14: 3822-3833, 1994.
29. Pelletier, J., and Sonenberg, N. Insertion mutagenesis to increase secondary structure within the 5′ noncoding region of a eukaryotic mRNA reduces translational efficiency. Cell, 40: 515-526, 1985.
30. Rao, C. D., Pech, M., Robbins, K. C., and Aaronson, S. A. The 5′ untranslated sequence of the c-sis/platelet-derived growth factor 2 transcript is a potent translational inhibitor. Mol. Cell. Biol., 8: 284-292, 1988.
31. Marth, J. D., Overell, R. W., Meier, K. E., Krebs, E. G., and Perlmutter, R. M. Translational activation of the lck proto-oncogene. Nature (Lond.), 332: 171-173, 1988.
32. Manzella, J. M., and Blackshear, P. J. Regulation of rat ornithine decarboxylase mRNA translation by its 5′-untranslated region. J. Biol. Chem., 265: 11817-11822, 1990.
33. Bates, B., Hardin, J., Zhan, X., Drickamer, K., and Goldfarb, M. Biosynthesis of human fibroblast growth factor-5. Mol. Cell. Biol., 11: 1840-1845, 1991.
34. Arrick, B. A., Lee, A. L., Grendell, R. L., and Derynck, R. Inhibition of translation of transforming growth factor-β 3 mRNA by its 5′ untranslated region. Mol. Cell. Biol., 11: 4306-4313, 1991.
35. Fagan, R. J., Lazaris Karatzas, A., Sonenberg, N., and Rozen, R. Translational control of ornithine aminotransferase. Modulation by initiation factor elF-4E. J. Biol. Chem., 266: 16518-16523, 1991.
36. Shantz, L. M., and Pegg, A. E. Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation. Cancer Res., 54: 2313-2316, 1994.
37. Ruan, H., Hill, J. R., Fatemie Nainie, S., and Morris, D. R. Cell-specific translational regulation of S-adenosylmethionine decarboxylase mRNA. Influence of the structure of the 5′ transcript leader on regulation by the upstream open reading frame. J. Biol. Chem., 269: 17905-17910, 1994.
38. Kevil, C., Carter, P., Hu, B., and DeBenedetti, A. Translational enhancement of FGF-2 by elF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation. Oncogene, 11: 2339-2348, 1995.
39. Mizokami, A., and Chang, C. Induction of translation by the 5′-untranslated region of human androgen receptor mRNA. J. Biol. Chem., 269: 25655-25659, 1994.
40. Hershey, J. W. Translational control in mammalian cells. Annu. Rev. Biochem., 60: 717-755, 1991.
41. Sonenberg, N. Cap-binding proteins of eukaryotic messenger RNA: functions in initiation and control of translation. Prog. Nucleic Acid Res. Mol. Biol., 35: 173-207, 1988.
42. Sonenberg, N., Morgan, M. A., Merrick, W. C., and Shatkin, A. J. A polypeptide in eukaryotic initiation factors that crosslinks specifically to the 5′-terminal cap in mRNA. Proc. Natl. Acad. Sci. USA, 75: 4843-4847, 1978.
43. Pause, A., M'ethot, N., Svitkin, Y., Merrick, W. C., and Sonenberg, N. Dominant negative mutants of mammalian translation initiation factor elF-4A define a critical role for elF-4F in cap-dependent and cap-independent initiation of translation. EMBO J., 13: 1205-1215, 1994.
44. Pause, A., and Sonenberg, N. Mutational analysis of a DEAD box RNA helicase: the mammalian translation initiation factor elF-4A. EMBO J., 11: 2643-2654, 1992.
45. Grifo, J. A., Tahara, S. M., Leis, J. P., Morgan, M. A., Shatkin, A. J., and Merrick, W. C. Characterization of eukaryotic initiation factor 4A, a protein involved in ATP-dependent binding of globin mRNA. J. Biol. Chem., 257: 5246-5252, 1982.
46. Ray, B. K., Lawson, T. G., Kramer, J. C., Cladaras, M. H., Grifo, J. A., Abramson, R. D., Merrick, W. C., and Thach, R. E. ATP-dependent unwinding of messenger RNA structure by eukaryotic initiation factors. J. Biol. Chem., 260: 7651-7658, 1985.
47. Rousseau, D., Kaspar, R., Rosenwald, I., Gehrke, L., and Sonenberg, N. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E. Proc. Natl. Acad. Sci. USA, 93: 1065-1070, 1996.
48. Darnell, J. E., Jr., Kerr, I. M., and Stark, G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (Washington, DC), 264: 1415-1421, 1994.
49. Reeves, R., Spies, G. A., Kiefer, M., Barr, P. J., and Power, M. Primary structure of the putative human oncogene, pim-1. Gene, 90: 303-307, 1990.
50. Kozak, M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res., 15: 8125-8148, 1987.
51. Zuker, M., and Stiegler, P. Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res., 9: 133-148, 1981.
52. Kozak, M. Influences of mRNA secondary structure on initiation by eukaryotic ribosomes. Proc. Natl. Acad. Sci. USA, 83: 2850-2854, 1986.
53. Koromilas, A. E., Lazaris Karatzas, A., and Sonenberg, N. mRNAs containing extensive secondary structure in their 5′ non-coding region translate efficiently in cells overexpressing initiation factor elF-4E (Published erratum in EMBO J., 11: 5138, 1992). EMBO J., 11: 4153-4158, 1992.
54. Kozak, M. Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6. EMBO J., 16: 2482-2492, 1997.
55. Genetics Computer Group Inc. Sequence Analysis Software Program, Version 7. Madison, WI: Genetics Computer Group Inc., 1991.
56. Rosenwald, I. B., Kaspar, R., Rousseau, D., Gehrke, L., Leboulch, P., Chen, J. J., Schmidt, E. V., Sonenberg, N., and London, I. M. Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and post-transcriptional levels. J. Biol. Chem., 270: 21176-21180, 1995.
57. Lazaris Karatzas, A., Montine, K. S., and Sonenberg, N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature (Lond.), 345: 544-547, 1990.
58. Rosenwald, I. B., Rhoads, D. B., Callahan, L. D., Isselbacher, K. J., and Schmidt, E. V. Increased expression of eukaryotic translation initiation factors elF-4E and elF-2 α in response to growth induction by c-myc. Proc. Natl. Acad. Sci. USA, 90: 6175-6178, 1993.
59. Ray, B. K., Brendler, T. G., Adya, S., Daniels McQueen, S., Miller, J. K., Hershey, J. W., Grifo, J. A., Merrick, W. C., and Thach, R. E. Role of mRNA competition in regulating translation: further characterization of mRNA discriminatory initiation factors. Proc. Natl. Acad. Sci. USA, 80: 663-667, 1983.
60. Mendez, R., Myers, M. G., Jr., White, M. F., and Rhoads, R. E. Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase. Mol. Cell. Biol., 16: 2857-2864, 1996.
61. Rosenwald, I. B., Lazaris Karatzas, A., Sonenberg, N., and Schmidt, E. V. Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E. Mol. Cell. Biol., 13: 7358-7363, 1993.
62. Breuer, M., Slebos, R., Verbeek, S., van Lohuizen, M., Wientjens, E., and Berns, A. Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice. Nature (Lond.), 340: 61-63, 1989.
63. De Benedetti, A., and Rhoads, R. E. Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. Proc. Natl. Acad. Sci. USA, 87: 8212-8216, 1990.
64. Klein, P. S., and Melton, D. A. Induction of mesoderm in Xenopus laevis embryos by translation initiation factor 4E. Science (Washington DC), 265: 803-806, 1994.
65. Brunn, G. J., Williams, J., Sabers, C., Wiederrecht, G., Lawrence, J. C., Jr., and Abraham, R. T. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J., 15: 5256-5267, 1996.
66. Bowlin, T. L., McKown, B. J., and Sunkara, P. S. Ornithine decarboxylase induction and polyamine biosynthesis are required for the growth of interleukin-2- and interleukin-3-dependent cell lines. Cell. Immunol., 98: 341-350, 1986.
67. Bercovich, Z., Rosenberg-Hasson, Y., Ciechanover, A., and Kahana, C. Degradation of ornithine decarboxylase in reticulocyte lysate is ATP-dependent but ubiquitin-independent. J. Biol. Chem., 264: 15949-15952, 1989.
68. Sherr, C. J., Matsushime, H., and Roussel, M. F. In: J. Marsh (ed.). Regulation of the Eukaryotic Cell Cycle, pp. 209-226. West Sussex: John Wiley & Sons, 1992.
69. Haystead, T. A., Haystead, C. M., Hu, C., Lin, T. A., and Lawrence, J. C., Jr. Phosphorylation of PHAS-I by mitogen-activated protein (MAP) kinase. Identification of a site phosphorylated by MAP kinase in vitro and in response to insulin in rat adipocytes. J. Biol. Chem., 269: 23185-23191, 1994.
70. Lin, T. A., Kong, X., Haystead, T. A., Pause, A., Belsham, G., Sonenberg, N., and Lawrence, J. C., Jr. PHAS-I as a link between mitogen-activated protein kinase and translation initiation. Science (Washington DC), 266: 653-656, 1994.
71. Rousseau, D., Gingras, A. C., Pause, A., and Sonenberg, N. The elF4E-binding proteins 1 and 2 are negative regulators of cell growth. Oncogene, 13: 2415-2420, 1996.
72. Beretta, L., Gingras, A. C., Svitkin, Y. V., Hall, M. N., and Sonenberg, N. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J., 15: 658-664, 1996.
73. Hutchcroft, J. E., Franklin, D. P., Tsai, B., Harrison Findik, D., Varticovski, L., and Bierer, B. E. Phorbol ester treatment inhibits phosphatidylinositol 3-kinase activation by, and association with, CD28, a T-lymphocyte surface receptor. Proc. Natl. Acad. Sci. USA, 92: 8808-8812, 1995.
74. Harlow, E., and Lane, D. Antibodies: A Laboratory Manual, pp. 53-135. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, New York. 1988.
75. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. (eds.). Current Protocols in Molecular Biology, pp. 3.1.1-4.10.9. New York: John Wiley & Sons, 1988.
76. Sambrook, J., Frisch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, pp. 61-207. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
77. Corsaro, C. M., and Pearson, M. L. Enhancing the efficiency of DNA-mediated gene transfer in mammalian cells. Somatic Cell Genet., 7: 603-616, 1981.